Alberto Penas-Steinhardt

Dr. Alberto Penas-Steinhardt

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IDIgnacio Dei-Cas
Ignacio Dei-Cas
Florencia GilibertoFlorencia Giliberto
Florencia Giliberto
LLLeonela Luce
Leonela Luce
HDHernán Dopazo
Hernán Dopazo
APAlberto Penas-Steinhardt
Alberto Penas-Steinhardt
Psoriasis is an immune-mediated skin disorder. Imbalance of gut microbial populations has been implicated in many diseases. We aimed to investigate whether there were differences in gut microbiota in psoriasis patients vs non-psoriasis controls and between psoriasis severity groups. 55 psoriasis patients and 27 controls were included. V3–V4 regions of the 16S rRNA gene of fecal samples were analyzed using Illumina MiSeq. Bioinformatic analysis was performed. We found changes in gut microbiome composition depending on their psoriasis status as determined by weighted unifrac (p < 0.05), in particular an increase in Firmicutes and depletion of Bacteroidetes in psoriasis patients. Additionally, theFaecalibacteriumandBlautiagenus were higher in psoriasis patients whileBacteroidesandParaprevotellain non-psoriasis controls (p < 0.05, LDA score > 2). Moderate-to-severe psoriasis patients had lower biodiversity than mild psoriatic patients (p = 0.049). No differences for beta-diversity were found. We developed a Psoriasis-Microbiota Index (PMI), which discriminated among psoriasis patients and controls with sensitivity: 0.78 and specificity: 0.79. Furthermore, we performed a meta-analysis with published data to validate this index. We demonstrated gut dysbiosis in psoriasis patients, suggesting a role in psoriasis pathophysiology. Furthermore, we developed a PMI with the potential to discriminate between psoriasis patients and controls across different populations, which could be used as a biomarker in the clinical practice.

1 May 2010 in Metabolism
Verified
Journal Article
Closed access
APAlberto Penas-Steinhardt
Alberto Penas-Steinhardt
FAFlorencia Aranguren
Florencia Aranguren
MTMariana Lorena Tellechea
Mariana Lorena Tellechea
LRLeonardo A. Gómez Rosso
Leonardo A. Gómez Rosso
FBFernando D. Brites
Fernando D. Brites
MTMariano J. Taverna
Mariano J. Taverna

29 December 2012 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
FBFiorella Sabrina Belforte
Fiorella Sabrina Belforte
FLF. Coluccio Leskow
F. Coluccio Leskow
EPE. Poskus
E. Poskus
APAlberto Penas-Steinhardt
Alberto Penas-Steinhardt

20 December 2011 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
APAlberto Penas-Steinhardt
Alberto Penas-Steinhardt
MTMariana Lorena Tellechea
Mariana Lorena Tellechea
LGLeonardo Gomez-Rosso
Leonardo Gomez-Rosso
FBFernando Brites
Fernando Brites
GFGustavo D Frechtel
Gustavo D Frechtel
EPEdgardo Poskus
Edgardo Poskus
Disturbances in leptin and insulin signaling pathways are related to obesity and metabolic syndrome (MS) with increased risk of diabetes and cardiovascular disease. Janus kinase 2 (JAK2) is a tyrosine kinase involved in the activation of mechanisms that mediate leptin and insulin actions. We conducted a population cross-sectional study to explore the association between two common variants in JAK2 gene and MS related traits in 724 Argentinean healthy male subjects.

11 March 2013 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
JGJimena Giudice
Jimena Giudice
LBLucia Soledad Barcos
Lucia Soledad Barcos
FGFrancisco F Guaimas
Francisco F Guaimas
APAlberto Penas-Steinhardt
Alberto Penas-Steinhardt
LGLuciana Giordano
Luciana Giordano
FLFederico Coluccio Leskow
Federico Coluccio Leskow
Background: Insulin and insulin-like growth factors (IGFs) act on tetrameric tyrosine kinase receptors controlling essential functions including growth, metabolism, reproduction and longevity. The insulin receptor (IR) binds insulin and IGFs with different affinities triggering different cell responses. Results: We showed that IGF-II induces cell proliferation and gene transcription when IR-B is over-expressed. We combined biotinylated ligands with streptavidin conjugated quantum dots and visible fluorescent proteins to visualize the binding of IGF-II and insulin to IR-B and their ensuing internalization. By confocal microscopy and flow cytometry in living cells, we studied the internalization kinetic through the IR-B of both IGF-II, known to elicit proliferative responses, and insulin, a regulator of metabolism. Conclusions: IGF-II promotes a faster internalization of IR-B than insulin. We propose that IGF-II differentially activates mitogenic responses through endosomes, while insulin-activated IR-B remains at the plasma membrane. This fact could facilitate the interaction with key effector molecules involved in metabolism regulation.

21 May 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
FBFiorella Sabrina Belforte
Fiorella Sabrina Belforte
NFNatalie Fernandez
Natalie Fernandez
FMFrancisco Tonín Monzón
Francisco Tonín Monzón
ARAyelén Daiana Rosso
Ayelén Daiana Rosso
SQSofía Quesada
Sofía Quesada
APAlberto Penas-Steinhardt
Alberto Penas-Steinhardt
In recent years, the field of immunology has been revolutionized by the growing understanding of the fundamental role of microbiota in the immune system function. The immune system has evolved to maintain a symbiotic relationship with these microbes. The aim of our study was to know in depth the uncharacterized metagenome of the Buenos Aires (BA) city population and its metropolitan area, being the second most populated agglomeration in the southern hemisphere. For this purpose, we evaluated 30 individuals (age: 35.23 ± 8.26 years and BMI: 23.91 ± 3.4 kg/m2), from the general population of BA. The hypervariable regions V3-V4 of the bacterial 16S gene was sequenced by MiSeq-Illumina system, obtaining 47526 ± 4718 sequences/sample. The dominant phyla were Bacteroidetes, Firmicutes, Proteobacteria, Verrucomicrobia, and Actinobacteria. Additionally, we compared the microbiota of BA with other westernized populations (Santiago de Chile, Rosario-Argentina, United States-Human-microbiome-project, Bologna-Italy) and the Hadza population of hunter-gatherers. The unweighted UniFrac clustered together all westernized populations, leaving the hunter-gatherer population from Hadza out. In particular, Santiago de Chile’s population turns out to be the closest to BA’s, principally due to the presence of Verrucomicrobiales of the genus Akkermansia. These microorganisms have been proposed as a hallmark of a healthy gut. Finally, westernized populations showed more abundant metabolism related KEEG pathways than hunter-gatherers, including carbohydrate metabolism (amino sugar and nucleotide sugar metabolism), amino acid metabolism (alanine, aspartate and glutamate metabolism), lipid metabolism, biosynthesis of secondary metabolites, and sulfur metabolism. These findings contribute to promote research and comparison of the microbiome in different human populations, in order to develop more efficient therapeutic strategies for the restoration of a healthy dialogue between host and environment.